B and T cell responses to the 3rd and 4th dose of the BNT162b2 vaccine in dialysis patients
Description
Patients on dialysis (PoD) are at high risk of severe morbidity and mortality from COVID-19. Characterizing long-term vaccine immune responses in these patients will help optimize vaccine schedule for PoD. This study aimed to determine whether long
